Showing results (41-50 of 276) with videos related to

Sort By:
Pageof 28
Archives of Gynecology and Obstetrics|February 20, 2016
The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implicationsIvo Meinhold-Heerlein, Christina Fotopoulou, Philipp Harter, et al.
Expert Review of Anticancer Therapy|July 24, 2013
Adjuvant therapy in node-positive vulvar cancerSven Mahner, Fabian Trillsch, Lilli Kock, et al.
Archives of Gynecology and Obstetrics|September 21, 2018
Is there a role for HIPEC in ovarian cancer?Philipp Harter, Andreas du Bois, Jalid Sehouli, et al.
Gynecologic Oncology|March 17, 2021
Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United StatesKoji Matsuo, Maximilian Klar, Philipp Harter, et al.
Annals of Surgical Oncology|February 19, 2010
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)Pauline Wimberger, Michael Wehling, Nils Lehmann, et al.
Gynecologic Oncology|August 24, 2010
Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinomaStefanie Scheil-Bertram, Patricia Tylus-Schaaf, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2025
Role of lymphadenectomy in advanced ovarian cancer-a subgroup analysis of the patients excluded from the LION trial (the Charité cohort)Robert Armbrust, Christina Fotopoulou, Dario Zocholl, et al.
Women'S Health (London, England)|September 2, 2011
Surgery for recurrent ovarian cancerFlorian Heitz, Andreas du Bois, Christian Kurzeder, et al.
Geburtshilfe Und Frauenheilkunde|October 27, 2018
Low-grade Serous Ovarian CarcinomaEnzo Ricciardi, Thaïs Baert, Beyhan Ataseven, et al.
Onkologie|February 8, 2012
Borderline tumors of the ovary: clinical course and prognostic factorsNina Ewald-Riegler, Oya du Bois, Annette Fisseler-Eckhoff, et al.
Pageof 28